Delaware § 4904 - Prescribing or administering of laetrile.

§ 4904. Prescribing or administering of laetrile.

(a) No hospital nor health facility may interfere with the physician-patient relationship by restricting or forbidding the use of laetrile (amygdalin, Vitamin B-17) when prescribed or administered by a physician, surgeon, osteopath or other person engaged in the “practice of medicine,” as that term is defined in § 1702 of Title 24 and/or when requested by a patient, unless the substance as prescribed or administered by the physician or medical practitioner is found to be harmful by the Board of Medical Licensure and Discipline in a public hearing which complies with the Freedom of Information Act [Chapter 100 of Title 29].

(b) No physician, surgeon, osteopath or other person engaged in the “practice of medicine,” as that term is defined in § 1702 of Title 24 shall be subject to disciplinary action solely for the prescribing or administering of laetrile (amygdalin, Vitamin B-17) to a patient under the physician's, surgeon's, osteopath's or other person's care who has requested the substance.

(c) Under this section laetrile shall not be considered a medical drug, but shall be considered a natural food substance.

61 Del. Laws, c. 90, §  2;  70 Del. Laws, c. 186, §  1;  75 Del. Laws, c. 141, §  2;  77 Del. Laws, c. 319, §  1;  80 Del. Laws, c. 80, §  2;  81 Del. Laws, c. 340, § 2;  82 Del. Laws, c. 75, § 3;  83 Del. Laws, c. 52, § 5;  84 Del. Laws, c. 422, § 1;  84 Del. Laws, c. 429, § 8;  85 Del. Laws, c. 102, § 1;